Brenda Mann's Insider Trades & SAST Disclosures

Brenda Mann's most recent trade in Kiora Pharmaceuticals Inc was a trade of 62 Common Stock done at an average price of $2.0 . Disclosure was reported to the exchange on Nov. 2, 2021.

Share

Note

This is a custom search result for pattern Brenda Mann.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Kiora Pharma Inc	Brenda Mann	VP of Research & Development	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.98 per share.	02 Nov 2021	62	15,136 (0%)	0%	2.0	123	Common Stock
Kiora Pharma Inc	Brenda Mann	VP of Research & Development	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.02 per share.	04 Oct 2021	62	15,198 (0%)	0%	2.0	125	Common Stock
Kiora Pharma Inc	Brenda Mann	VP of Research & Development	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.80 per share.	02 Sep 2021	61	15,260 (0%)	0%	1.8	110	Common Stock
Kiora Pharma Inc	Brenda Mann	VP of Research & Development	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.40 per share.	03 Aug 2021	63	15,321 (0%)	0%	2.4	151	Common Stock
Kiora Pharma Inc	Brenda Mann	VP of Research & Development	Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share.	02 Jul 2021	154	15,384 (0%)	0%	3.7	570	Common Stock
Kiora Pharma Inc	Brenda Mann	VP of Research & Development	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.19 per share.	04 Jun 2021	155	15,538 (0%)	0%	4.2	649	Common Stock
Kiora Pharma Inc	Brenda Mann	VP of Research & Development	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.13 per share.	04 May 2021	191	15,693 (0%)	0%	4.1	789	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades